Table 3.
Current literature on the management of CSDH in super-aged patients aged 90 years and older.
| Authors | Patients number | Surgery/ conservative | Surgery outcomes after 6 months | Research conclusions | ||
|---|---|---|---|---|---|---|
| Improved | Recurrence | Death | ||||
| Stippler et al. (20) | 21 | 16/5 | 38% | 12.5% | 31% | Surgical and conservative care both result in poor outcomes. |
| Tabuchi et al. (19) | 20 | 12/8 | N/A | N/A | N/A | Surgery is considered safe and recommended for super-aged patients in good physical condition. |
| Lee et al. (9) | 101 | 70/31 | N/A | 12.9% | 18.6% | It is beneficial and safe to surgically treat CSDH in super-aged patients. |
| Bartek et al (23) | 75 | 75/0 | N/A | 10.7% | 13.3% | Surgery result in a higher incidence of 90-day mortality compared to younger patients with CSDH. |
| Dobran et al (24) | 25 | 25/0 | 96% | 20% | 4% | Surgery for CSDH in patients over 90 is as safe and effective as that in patients under 90, but with higher recurrence. |
| Christopher et al (22) | 68 | 68/0 | 48.5% | 11.8% | 8.8% | Surgery result in increased mortality and disability. |
| Ewbank et al (10) | 41 | 41/0 | N/A | N/A | 26.8% | Surgery can be safety in selected super-aged patients, but overall mortality is high. |
| Chiappini et al. (21) | 22 | 22/0 | 77.3% | 18.2% | 9.5% | Age was not directly correlated with greater recurrence, postoperative bleeding, or mortality rates. |
N/A, not available.